The mechanisms of microgliosis and pain following peripheral nerve injury

Microglia are the resident macrophages in the central nervous system (CNS). Any insult to the CNS homeostasis will induce a rapid change in microglia morphology, gene expression profile and functional behaviour. These responses of microglia have been collectively known as 'microgliosis'. Interestingly, damage to the nervous system outside the CNS, such as axotomy of a peripheral nerve, can lead to microgliosis in the spinal cord. There is a variation in the degree of microgliosis depending on the model of nerve injury employed for instance this response is more marked following traumatic nerve injury than in models of chemotherapy induced neuropathy. Following peripheral nerve injury nociceptive inputs from sensory neurons appear to be critical in triggering the development of spinal microgliosis. A number of signalling pathways including growth factors such as Neuregulin-1, matrix metalloproteases such as MMP-9 and multiple chemokines enable direct communication between injured primary afferents and microglia. In addition, we describe a group of mediators which although not demonstrably shown to be released from neurons are known to modulate microglial phenotype. There is a great functional diversity of the microglial response to peripheral nerve injury which includes: Cellular migration, proliferation, cytokine release, phagocytosis, antigen presentation and recruitment of T cells. It should also be noted that in certain contexts microglia may have a role in the resolution of neuro-inflammation. Although there is still no direct evidence demonstrating that spinal microglia have a role in neuropathic pain in humans, these patients present a pro-inflammatory cytokine profile and it is a reasonable hypothesis that these cells may contribute to this inflammatory response. Modulating microglial functions offers a novel therapeutic opportunity following nerve injury which ideally would involve reducing the pro-inflammatory nature of these cells whilst retaining their potential beneficial functions.

[1]  M. Woodroofe,et al.  Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro , 1999, Journal of neuroscience research.

[2]  T. Möller,et al.  Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton , 1996, Neuroscience.

[3]  N. Stella,et al.  Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: Quantification of migration by a novel near‐infrared method , 2009, Glia.

[4]  J. Loeb,et al.  Neuregulin-ErbB Signaling Promotes Microglial Proliferation and Chemotaxis Contributing to Microgliosis and Pain after Peripheral Nerve Injury , 2010, The Journal of Neuroscience.

[5]  J.L.O'L.,et al.  Chemical Pathology of the Nervous System (Proceedings of the Third International Neurochemical Symposium held at Strasbourg, 1958) , 1962, Neurology.

[6]  Jin Mo Chung,et al.  An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.

[7]  R. von Bernhardi,et al.  Modulation by Astrocytes of Microglial Cell-Mediated Neuroinflammation: Effect on the Activation of Microglial Signaling Pathways , 2007, Neuroimmunomodulation.

[8]  G. Kreutzberg,et al.  Inhibition of Posttraumatic Microglial Proliferation in a Genetic Model of Macrophage Colony‐Stimulating Factor Deficiency in the Mouse , 1994, The European journal of neuroscience.

[9]  J. Deleo,et al.  CNS‐infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection‐induced neuropathic pain , 2008, European journal of immunology.

[10]  Atsushi Tokunaga,et al.  Activating Transcription Factor 3 (ATF3) Induction by Axotomy in Sensory and Motoneurons: A Novel Neuronal Marker of Nerve Injury , 2000, Molecular and Cellular Neuroscience.

[11]  S. Kohsaka,et al.  Macrophage‐colony stimulating factor as an inducer of microglial proliferation in axotomized rat facial nucleus , 2010, Journal of neurochemistry.

[12]  Kirk W. Johnson,et al.  Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10 , 2005, The European journal of neuroscience.

[13]  Maria Fitzgerald,et al.  T-Cell Infiltration and Signaling in the Adult Dorsal Spinal Cord Is a Major Contributor to Neuropathic Pain-Like Hypersensitivity , 2009, The Journal of Neuroscience.

[14]  G. Kreutzberg,et al.  Displacement of synaptic terminals from regenerating motoneurons by microglial cells , 2004, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[15]  O. Soehnlein,et al.  Phagocyte partnership during the onset and resolution of inflammation , 2010, Nature Reviews Immunology.

[16]  B. Trapp,et al.  Evidence for synaptic stripping by cortical microglia , 2007, Glia.

[17]  A. Eschalier,et al.  Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain , 1993, Pain.

[18]  M. Etienne,et al.  Phosphorylation of spinal N-methyl-d-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy. , 2011, European journal of pain.

[19]  M. Malcangio,et al.  The Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S , 2009, The Journal of Neuroscience.

[20]  S. Ho,et al.  Inhibition of p38 mitogen‐activated protein kinase attenuates interleukin‐1β‐induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord , 2005, Journal of neurochemistry.

[21]  S. Koizumi,et al.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.

[22]  S. Nedergaard,et al.  Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain , 2009, European journal of pain.

[23]  K. Jacobson,et al.  UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis , 2007, Nature.

[24]  Clifford J. Woolf,et al.  Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity , 2007, The Journal of Neuroscience.

[25]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[26]  V. Perry A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation , 1998, Journal of Neuroimmunology.

[27]  Stephen P. H. Alexander,et al.  Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain , 2009, Molecular pain.

[28]  I. Maridonneau-Parini,et al.  Complement Receptor 3 (CD11b/CD18) Mediates Type I and Type II Phagocytosis During Nonopsonic and Opsonic Phagocytosis, Respectively1 , 2002, The Journal of Immunology.

[29]  Y. Imai,et al.  Extracellular ATP or ADP Induce Chemotaxis of Cultured Microglia through Gi/o-Coupled P2Y Receptors , 2001, The Journal of Neuroscience.

[30]  Kazuhide Inoue,et al.  Extracellular ATP Triggers Tumor Necrosis Factor‐α Release from Rat Microglia , 2000 .

[31]  S. Maier,et al.  Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain , 2009, The Journal of Neuroscience.

[32]  R. P. Landry,et al.  Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation , 2009, Molecular pain.

[33]  Kazuhide Inoue,et al.  Involvement of P2X4 and P2Y12 receptors in ATP‐induced microglial chemotaxis , 2007, Glia.

[34]  John Grist,et al.  CCL2 is a key mediator of microglia activation in neuropathic pain states , 2009, European journal of pain.

[35]  V. Tawfik,et al.  Neuregulin 1 is a pronociceptive cytokine that is regulated by progesterone in the spinal cord: Implications for sex specific pain modulation , 2008, European journal of pain.

[36]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[37]  P. Mcgeer,et al.  Brain microglia constitutively express beta-2 integrins. , 1990, Journal of neuroimmunology.

[38]  J. Sagen,et al.  Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis , 2001, Journal of Neuroimmunology.

[39]  Yang Ping,et al.  Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model , 2010, Molecular pain.

[40]  M. Svensson,et al.  Synaptic Density of Axotomized Hypoglossal Motorneurons Following Pharmacological Blockade of the Microglial Cell Proliferation , 1993, Experimental Neurology.

[41]  V. Perry,et al.  Turnover of resident microglia in the normal adult mouse brain , 1992, Neuroscience.

[42]  H. Tozaki-Saitoh,et al.  Nerve injury‐activated microglia engulf myelinated axons in a P2Y12 signaling‐dependent manner in the dorsal horn , 2010, Glia.

[43]  R. Ji,et al.  Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine , 2007, Brain, Behavior, and Immunity.

[44]  Christopher B Wilson,et al.  Regulation of interferon-gamma during innate and adaptive immune responses. , 2007, Advances in immunology.

[45]  R. Ji,et al.  Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord , 2008, The Journal of Neuroscience.

[46]  G. Wasner,et al.  Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[47]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[48]  W. Gan,et al.  The P2Y12 receptor regulates microglial activation by extracellular nucleotides , 2006, Nature Neuroscience.

[49]  J. Deleo,et al.  Spinal Microglial and Perivascular Cell Cannabinoid Receptor Type 2 Activation Reduces Behavioral Hypersensitivity without Tolerance after Peripheral Nerve Injury , 2008, Anesthesiology.

[50]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[51]  J. Deleo,et al.  Minocycline decreases in vitro microglial motility, β1‐integrin, and Kv1.3 channel expression , 2007, Journal of neurochemistry.

[52]  J. Loeb,et al.  Following Nerve Injury Neuregulin-1 Drives Microglial Proliferation and Neuropathic Pain via the MEK/ERK Pathway , 2011, Glia.

[53]  Andrew R Segerdahl,et al.  Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. , 2007, Brain : a journal of neurology.

[54]  P. Rakić,et al.  Transganglionic degenerative atrophy in the substantia gelatinosa of the spinal cord after peripheral nerve transection in rhesus monkeys , 1987, Cell and Tissue Research.

[55]  J. Deleo,et al.  Propentofylline attenuates vincristine-induced peripheral neuropathy in the rat , 2006, Neuroscience Letters.

[56]  C. Woolf,et al.  p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.

[57]  L. Mei,et al.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia , 2008, Nature Reviews Neuroscience.

[58]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[59]  M. Etienne,et al.  Diabetes-Induced Mechanical Hyperalgesia Involves Spinal Mitogen-Activated Protein Kinase Activation in Neurons and Microglia via N-Methyl-D-aspartate-Dependent Mechanisms , 2006, Molecular Pharmacology.

[60]  S. Maier,et al.  Intrathecal HIV-1 Envelope Glycoprotein gp120 Induces Enhanced Pain States Mediated by Spinal Cord Proinflammatory Cytokines , 2001, The Journal of Neuroscience.

[61]  S. Beggs,et al.  Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury , 2007, Brain, Behavior, and Immunity.

[62]  N. Calcutt,et al.  Activation of p38 mitogen‐activated protein kinase in spinal microglia is a critical link in inflammation‐induced spinal pain processing , 2003, Journal of neurochemistry.

[63]  L. Lao,et al.  Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia , 2005, Pain.

[64]  S. Maier,et al.  Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions , 2004, The European journal of neuroscience.

[65]  J. Deleo,et al.  Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[66]  Ji Zhang,et al.  Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain , 2008, PAIN®.

[67]  P. Ji,et al.  Corticotropin‐releasing hormone induces proliferation and TNF‐α release in cultured rat microglia via MAP kinase signalling pathways , 2002, Journal of neurochemistry.

[68]  M. Rudin,et al.  Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat , 2000, Experimental Brain Research.

[69]  V. Perry,et al.  Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.

[70]  P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways , 2010, Journal of neurochemistry.

[71]  Ping-Heng Tan,et al.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.

[72]  C. Coe,et al.  Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients , 2008, Journal of Neuroimmunology.

[73]  Hosung Jung,et al.  Chemokines and the pathophysiology of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[74]  John C. Lee,et al.  Extracellular Signal-Regulated Kinase and p38 Subgroups of Mitogen-Activated Protein Kinases Regulate Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-α Gene Expression in Endotoxin-Stimulated Primary Glial Cultures , 1998, The Journal of Neuroscience.

[75]  John D. Lambris,et al.  The Classical Complement Cascade Mediates CNS Synapse Elimination , 2007, Cell.

[76]  M. Malcangio,et al.  Gabapentin reverses microglial activation in the spinal cord of streptozotocin‐induced diabetic rats , 2009, European journal of pain.

[77]  H. Neumann,et al.  Microglial clearance function in health and disease , 2009, Neuroscience.

[78]  S. Rivest,et al.  Bone-marrow-derived microglia: myth or reality? , 2008, Current opinion in pharmacology.

[79]  Ronald Dubner,et al.  A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury , 1990, Pain.

[80]  N. Carruthers,et al.  Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain , 2005, The Journal of Neuroscience.

[81]  M. Svensson,et al.  A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat , 1993, Experimental Brain Research.

[82]  M. Weinstock,et al.  Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats , 2003, Experimental Neurology.

[83]  R. Lecomte,et al.  Behavioral, Medical Imaging and Histopathological Features of a New Rat Model of Bone Cancer Pain , 2010, PloS one.

[84]  S. Papson,et al.  “Model” , 1981 .

[85]  Gary J. Bennett,et al.  Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction , 2006, Pain.

[86]  M. Fitzgerald,et al.  Brief, low frequency stimulation of rat peripheral C-fibres evokes prolonged microglial-induced central sensitization in adults but not in neonates , 2009, PAIN®.

[87]  S. Koizumi,et al.  Activation of p38 mitogen‐activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury , 2004, Glia.

[88]  p38 MAPK, microglial signaling, and neuropathic pain , 2007, Molecular pain.

[89]  H. Zeilhofer Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia. , 2008, International immunopharmacology.

[90]  P. Mantyh,et al.  Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain , 2005, Experimental Neurology.

[91]  Kazuhide Inoue,et al.  Purinergic systems in microglia , 2008, Cellular and Molecular Life Sciences.

[92]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[93]  F. Rossi,et al.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.

[94]  R. Gross,et al.  Adenosine A2A receptor mediates microglial process retraction , 2009, Nature Neuroscience.

[95]  A. Todd,et al.  Loss of Neurons from Laminas I-III of the Spinal Dorsal Horn Is Not Required for Development of Tactile Allodynia in the Spared Nerve Injury Model of Neuropathic Pain , 2005, The Journal of Neuroscience.

[96]  S. Akira,et al.  THIS ARTICLE HAS BEEN RETRACTED: Toll‐like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury , 2008, Journal of neurochemistry.

[97]  Anirban Basu,et al.  Inflammasome signaling at the heart of central nervous system pathology , 2010, Journal of neuroscience research.

[98]  J. Antel,et al.  TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1 , 2005, The Journal of Immunology.

[99]  O. Sasso,et al.  Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor , 2010, Glia.

[100]  R. Myers,et al.  Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury , 2001, Neuroreport.

[101]  J. Deleo,et al.  The Effect of Site and Type of Nerve Injury on Spinal Glial Activation and Neuropathic Pain Behavior , 1999, Experimental Neurology.

[102]  S. McMahon,et al.  P2X7-Dependent Release of Interleukin-1β and Nociception in the Spinal Cord following Lipopolysaccharide , 2010, The Journal of Neuroscience.

[103]  G. Bennett,et al.  The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries , 2011, Neuroscience.

[104]  I. Obrosova Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments , 2009, Neurotherapeutics.

[105]  S. Talbot,et al.  Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy , 2010, Journal of Neuroinflammation.

[106]  S. Opal,et al.  Anti-inflammatory cytokines. , 2000, Chest.

[107]  H. Boddeke,et al.  Neuronal CCL21 up‐regulates microglia P2X4 expression and initiates neuropathic pain development , 2011, The EMBO journal.

[108]  S. Maier,et al.  An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine , 2005, The European journal of neuroscience.

[109]  Kirk W. Johnson,et al.  Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats , 2007, Brain, Behavior, and Immunity.

[110]  P. Daull,et al.  Inhibition of Type 1 Diabetic Hyperalgesia in Streptozotocin-Induced Wistar versus Spontaneous Gene-Prone BB/Worchester Rats: Efficacy of a Selective Bradykinin B1 Receptor Antagonist , 2005, Journal of neuropathology and experimental neurology.

[111]  J. Deleo,et al.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Charles N Serhan,et al.  Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions , 2010, Nature Medicine.

[113]  H. Tozaki-Saitoh,et al.  P2Y12 Receptors in Spinal Microglia Are Required for Neuropathic Pain after Peripheral Nerve Injury , 2008, The Journal of Neuroscience.

[114]  H. Shimoyama,et al.  IFN-γ receptor signaling mediates spinal microglia activation driving neuropathic pain , 2009, Proceedings of the National Academy of Sciences.

[115]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[116]  R. Schwartzman,et al.  Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome , 2009, Brain, Behavior, and Immunity.

[117]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[118]  F. Helmchen,et al.  Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.

[119]  Erin R. Reichenberger,et al.  Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome , 2007, Brain, Behavior, and Immunity.

[120]  A. Sauter,et al.  Ischemia‐induced neuronal expression of the microglia attracting chemokine secondary lymphoid‐tissue chemokine (SLC) , 2001, Glia.

[121]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[122]  Andrew S.C. Rice,et al.  Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy , 2007, PAIN®.

[123]  C. Woolf,et al.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.

[124]  H. Kettenmann,et al.  Purinergic signaling and microglia , 2006, Pflügers Archiv.

[125]  P. Mcgeer,et al.  Brain microglia constitutively express β-2 integrins , 1990, Journal of Neuroimmunology.

[126]  B. McEwen,et al.  Acute in vivo exposure to interferon-γ enables resident brain dendritic cells to become effective antigen presenting cells , 2009, Proceedings of the National Academy of Sciences.

[127]  C. D. Palmer,et al.  Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain , 2009, European journal of immunology.

[128]  D. Coyle,et al.  Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior , 1998, Glia.

[129]  C. Chen,et al.  Chronic Intrathecal Infusion of Minocycline Prevents the Development of Spinal-Nerve Ligation-Induced Pain in Rats , 2007, Regional Anesthesia & Pain Medicine.

[130]  J. Mudgett,et al.  Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[131]  C. Gravel,et al.  BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.

[132]  R. Maki,et al.  Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. , 1999, Journal of immunology.

[133]  S. Koizumi,et al.  Mechanisms underlying extracellular ATP‐evoked interleukin‐6 release in mouse microglial cell line, MG‐5 , 2001, Journal of neurochemistry.

[134]  W. Hickey,et al.  Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat , 1997, Journal of Neuroimmunology.

[135]  G. Y. Wong,et al.  Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells , 2007, Experimental Neurology.

[136]  H. Tozaki-Saitoh,et al.  Pain and purinergic signaling , 2010, Brain Research Reviews.

[137]  S. Maier,et al.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation , 2005, Pain.

[138]  Osamu Yoshie,et al.  Chemokine/chemokine receptor nomenclature. , 2003, Cytokine.

[139]  G. Núñez,et al.  The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis , 2009, Nature Immunology.

[140]  S. Akira,et al.  A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity* , 2007, Journal of Biological Chemistry.

[141]  I. Decosterd,et al.  Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury , 2009, Molecular pain.

[142]  Y. Nakata,et al.  Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. , 2000, Journal of neurochemistry.

[143]  M. Pauza,et al.  Direct Role of Streptozotocin in Inducing Thermal Hyperalgesia by Enhanced Expression of Transient Receptor Potential Vanilloid 1 in Sensory Neurons , 2008, Molecular Pharmacology.

[144]  C. Colton,et al.  Chemotaxis by a CNS macrophage, the microglia , 1990, Journal of neuroscience research.

[145]  H. Ueno,et al.  Activation of dorsal horn microglia contributes to diabetes‐induced tactile allodynia via extracellular signal‐regulated protein kinase signaling , 2008, Glia.

[146]  F. D’Acquisto,et al.  Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells , 2011, Journal of Neuroimmunology.

[147]  C. Woolf,et al.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.

[148]  Sunhee C. Lee,et al.  Inhibition of Granulocyte-Macrophage Colony-Stimulating Factor Signaling and Microglial Proliferation by Anti-CD45RO: Role of Hck Tyrosine Kinase and Phosphatidylinositol 3-Kinase/Akt1 , 2005, The Journal of Immunology.

[149]  S. Beggs,et al.  P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase Activation , 2009, The Journal of Neuroscience.

[150]  J. Deleo,et al.  The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents , 2002, Journal of Neuroimmunology.

[151]  Y. de Koninck,et al.  Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain , 2007, The Journal of Neuroscience.

[152]  A. Mildner,et al.  Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions , 2007, Nature Neuroscience.

[153]  De-sheng Wang,et al.  Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes , 2011, Brain Research.

[154]  H. Boddeke,et al.  Vesicle-Mediated Transport and Release of CCL21 in Endangered Neurons: A Possible Explanation for Microglia Activation Remote from a Primary Lesion , 2005, The Journal of Neuroscience.

[155]  S. Miller,et al.  Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1 , 2004, The Journal of Immunology.

[156]  S. McMahon,et al.  Rapid co‐release of interleukin 1β and caspase 1 in spinal cord inflammation , 2006, Journal of neurochemistry.

[157]  H. Baba,et al.  Visualization of the cervical spinal cord with FDG and high-resolution PET. , 1998, Journal of computer assisted tomography.

[158]  G. Dienel,et al.  Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats , 2006, Neurobiology of Disease.